Trials / Completed
CompletedNCT00167921
Study Comparing Premarin® Vaginal Cream Versus Premarin® Oral Tablets in Atrophic Vaginitis
A Multiple-Dose, Comparative Bioavailability Study of Premarin® Vaginal Cream Versus Premarin® Oral Tablets in Postmenopausal Women With Atrophic Vaginitis.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (planned)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- Female
- Age
- 45 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to characterize the systemic exposure and bioavailability at steady state of Premarin® Vaginal Cream compared with Premarin® oral tablets in postmenopausal women with atrophic vaginitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Premarin® Vaginal Cream | |
| DRUG | Premarin® oral tablets |
Timeline
- Start date
- 2005-10-01
- First posted
- 2005-09-14
- Last updated
- 2007-05-28
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00167921. Inclusion in this directory is not an endorsement.